Hereditary Cancer Program
St. Elizabeth Healthcare has the only Comprehensive Hereditary Cancer Program in the tri-state area with full-time staff genetic counselors dedicated to working with women and families at increased risks for hereditary cancers.
Genetic testing for hereditary cancer syndromes and cancer susceptibility can be made available to patients with appropriate personal or family histories. These genetic test results can be used to make specific screening and management recommendations for your care in the future.
At St. Elizabeth Healthcare, we offer comprehensive genetic counseling, hereditary cancer risk assessment and high-risk management for:
- Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2)
- Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
- Familial Adenomatous Polyposis (FAP)
- Cowden syndrome
- Li-Fraumeni Syndrome
- Von Hippel-Lindau syndrome and other rare hereditary cancer syndromes
Here are a few questions to ask yourself to see whether or not hereditary cancer testing is appropriate for you:
- Do you have concerns about a family history of cancer?
- Were you diagnosed with breast, ovarian, or colon cancer before the age of 50?
- Do you have family members who were diagnosed with breast, ovarian, colon or uterine cancer at a young age?
- Are there family members on either your mother’s or your father’s side of the family who have had early onset cancer or multiple cancers?
- Has anyone in your family been told they have breast cancer more than once?
After your screening, personalized management options will be developed to help meet your needs and healthy living goals.
For more information, including the recommended age to begin screening and questions regarding insurance coverage, or to speak to a genetic counselor directly, please call (859) 301-5396.
If you are ready to schedule an appointment, please call central scheduling at (859) 655-7400. For insurance purposes, we prefer that you have a referral form from a physician before making an appointment.
Take the Breast Cancer Risk Assessment